Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma

Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-25T13:25:42.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T13:43:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T14:27:37.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry was added to the study record history, updating the version history. The previous Revision: v3.6.6 entry was removed.
    Difference
    0.1%
    Check dated 2026-09-20T20:20:03.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page's revision history shows a new entry: Revision: v3.6.6. The previous revision, v3.6.5, was removed, indicating a minor site update to the study record history.
    Difference
    0.1%
    Check dated 2026-08-30T21:58:49.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.5, was added to the history, and the previous entry Revision: v3.6.4 was removed from the list.
    Difference
    0.1%
    Check dated 2026-08-09T11:06:56.000Z thumbnail image

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma

Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.